Noncanonical functions of telomerase: implications in telomerase-targeted cancer therapies.
about
Telomerase reverse transcriptase regulates microRNAsRoles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapiesTelomere and Telomerase Therapeutics in CancerReactivation of telomerase in cancerTelomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.B1, a novel HDAC inhibitor, induces apoptosis through the regulation of STAT3 and NF-κB.Low expression of PinX1 is associated with malignant behavior in basal-like breast cancerAssociation of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity.Saccharomyces cerevisiae as a model for the study of extranuclear functions of mammalian telomeraseTelomere Length, TERT, and miRNA ExpressionERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosisParacrine regulation in mesenchymal stem cells: the role of Rap1.Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virusTelomerase reverse transcriptase acts in a feedback loop with NF-κB pathway to regulate macrophage polarization in alcoholic liver disease.Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.Telomerase reactivation in cancers: Mechanisms that govern transcriptional activation of the wild-type vs. mutant TERT promotersImmunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patients.Reactivation of Tert in the medial prefrontal cortex and hippocampus rescues aggression and depression of Tert(-/-) mice.PinX1 suppresses tumorigenesis by negatively regulating telomerase/telomeres in colorectal carcinoma cells and is a promising molecular marker for patient prognosis.Rap1-mediated nuclear factor-kappaB (NF-κB) activity regulates the paracrine capacity of mesenchymal stem cells in heart repair following infarctionTelomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expressionActivation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas.Inhibition of NUCKS Facilitates Corneal Recovery Following Alkali BurnCurrent Insights to Regulation and Role of Telomerase in Human Diseases.Cellular aging in depression: Permanent imprint or reversible process?: An overview of the current evidence, mechanistic pathways, and targets for interventions.Treating Cancer by Targeting Telomeres and Telomerase.Analysis of the intricate relationship between chronic inflammation and cancer.Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells.Quantitative assessment of telomerase components in cancer cell lines.Wanted DEAD/H or Alive: Helicases Winding Up in Cancers.Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology.The Role of Pontin and Reptin in Cellular Physiology and Cancer Etiology.Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 Cancer cells with PX-866 and Raloxifene.NFκB drives TERT promoter reactivation in cancer.Catalytically inactive telomerase in oncogenesis.Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cells.Telomere Biology and Thoracic Aortic Aneurysm.Distinct Responses of Stem Cells to Telomere Uncapping-A Potential Strategy to Improve the Safety of Cell Therapy.
P2860
Q24313154-296F6D6B-547A-4F26-828E-B1744C7D9109Q26744271-32B450A0-66DB-4B0A-98CF-40C2D9A05372Q26744808-40AC0BDA-DC40-401B-AF4D-EF16775A6CB6Q26769014-C69AD2D7-F2A9-4BCF-A363-F0B78F712A69Q30248577-733921DD-28C9-4B4C-B0A7-B631D6169C96Q33597695-2F95773B-A63F-4F54-97C4-31DFEAC76096Q33858225-20F3B6EC-872C-4D25-A337-F6BC92F8D574Q35644577-A84457FF-DFBB-4A65-9DEB-43605BE4B34FQ35720003-497EBA0C-4934-4E62-999F-FB9BBB676621Q35832834-8F10BDE1-E46A-4CC8-A01C-47D2871A6A65Q36132829-D964E748-C4A9-411C-BADF-7A9711DB6EFDQ36175526-47154DFD-9262-4BDC-AC35-77F6A1303359Q36246474-FCD8727A-CA71-4D16-8BBE-F95AD37D792DQ36346985-72A16D48-BB11-482C-9FEC-2DDF6E532F6FQ36423119-183A88AC-1EB2-451C-81F2-D75C3F745969Q36635311-9A0B1472-7E04-4D5F-A59B-D08D1CF6474CQ36857933-0D6C23D3-75D8-4F35-A62C-280312F14E3EQ37012876-A86CB361-B3AC-4F6B-81F7-A051BB4D6BCAQ37061862-C9D83214-E633-4A85-84AC-43F3E4A23D7BQ37158545-622E2C00-8A31-4D11-BB0E-68808E277523Q37167471-ADEB0A49-4252-42F1-8F62-246C079F4EE8Q37395716-30C2889F-F344-4D86-B4C9-A6DBB56093ACQ37514988-1F1AA617-F339-401A-B734-CC14EA94F277Q37595322-8E8A13B0-DC61-42C2-BE5D-6C28DFAB70ACQ37741228-F68E0A99-3B6E-484E-87ED-F419DA9890E6Q38241808-F9194374-6FAE-4E63-A99E-C12C178C1808Q38288984-8611AD8A-D365-4EF1-B1A1-2612EB938081Q38458724-78DE2B54-5797-42F1-9F38-7554579CDF60Q38739821-0FCF7FCA-759F-43B8-A529-C63525E93330Q38902476-554BFA9B-9474-4360-84BE-BAB0BDC2BC8FQ38998990-83959749-7AED-42FC-8EB0-8E491D1DFC6CQ40621306-4FD6454B-1ED4-40F2-B6DE-85EB7737CD35Q41539424-6BE12885-6339-47D4-8646-A832E1B1DE83Q42182370-76677367-F2F7-4343-B5D7-495F1E065439Q42764417-258546DC-9461-413D-93BA-7CCFABD84C8AQ42910096-26FC55E7-0122-4941-BF15-922345396EDEQ43060096-A124FC2A-4B22-41E3-9749-E37BC55C63BEQ47107766-7EF97F56-6595-4AE9-9DD9-8B74305A06EAQ47265486-D8394129-D956-49B8-95B4-7D1F823BE438Q48200984-63706291-6829-4705-A558-2E3CCDB02780
P2860
Noncanonical functions of telomerase: implications in telomerase-targeted cancer therapies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Noncanonical functions of telo ...... ase-targeted cancer therapies.
@en
type
label
Noncanonical functions of telo ...... ase-targeted cancer therapies.
@en
prefLabel
Noncanonical functions of telo ...... ase-targeted cancer therapies.
@en
P1433
P1476
Noncanonical functions of telo ...... ase-targeted cancer therapies.
@en
P2093
Vinay Tergaonkar
P304
P356
10.1158/0008-5472.CAN-13-3568
P407
P50
P577
2014-03-05T00:00:00Z